Article info
PDFCommentary
‘Green’ bioethics widens the scope of eligible values and overrides patient demand: comment on Parker
- Correspondence to Professor Christian Munthe, Department of Philosophy, Linguistics & Theory of Science, University of Gothenburg, Goteborg 405 30, Sweden; christian.munthe{at}gu.se
Citation
‘Green’ bioethics widens the scope of eligible values and overrides patient demand: comment on Parker
Publication history
- Received December 14, 2022
- Accepted December 14, 2022
- First published December 23, 2022.
Online issue publication
May 18, 2023
Article Versions
- Previous version (27 April 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Barriers to green inhaler prescribing: ethical issues in environmentally sustainable clinical practice
- Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
- Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England
- Inhaler devices for asthma
- Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries
- Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma
- Challenges in changing to non-chlorofluorocarbon inhalers in the treatment of asthma
- P229 Factors affecting inhaler choice and adherence in urban Liverpool
- Carbon footprint impact of the choice of inhalers for asthma and COPD
- The scope of patient, healthcare professional and healthcare systems responsibilities to reduce the carbon footprint of inhalers: a response to commentaries